Maternal serum thromboxane B2 concentrations do not predict improved outcomes in high-risk pregnancies in a low-dose aspirin trial. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medical Units (Q77580450)
Jump to navigation
Jump to search
scientific article published on 01 November 1998
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Maternal serum thromboxane B2 concentrations do not predict improved outcomes in high-risk pregnancies in a low-dose aspirin trial. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medical Units |
scientific article published on 01 November 1998 |
Statements
Maternal serum thromboxane B2 concentrations do not predict improved outcomes in high-risk pregnancies in a low-dose aspirin trial. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medical Units (English)
M Miodovnik
B Sibai
S Caritis
P VanDorsten
M Lindheimer
M Klebanoff
C MacPherson
M Landon
R Paul
P Meis
M Dombrowski
G Thurnau
S Walsh
D McNellis
1 November 1998
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference